vs
Side-by-side financial comparison of Drugs Made In America Acquisition II Corp. (DMII) and Lakeshore Acquisition III Corp. (LCCC). Click either name above to swap in a different company.
Drugs Made In America Acquisition II Corp. is a special purpose acquisition company (SPAC) focused on pursuing business combination opportunities with U.S.-based pharmaceutical, biotechnology and medical product manufacturing firms, with a core priority of supporting domestic healthcare supply chain stability.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
Revenue
DMII
LCCC
| Q3 25 | — | $717.3K | ||
| Q2 25 | — | $467.3K |
Net ProfitDMIILCCC
| Q3 25 | — | $486.8K | ||
| Q2 25 | — | $216.5K |
Operating MarginDMIILCCC
| Q3 25 | — | -32.1% | ||
| Q2 25 | — | -53.7% |
Net MarginDMIILCCC
| Q3 25 | — | 67.9% | ||
| Q2 25 | — | 46.3% |
EPS (diluted)DMIILCCC
| Q3 25 | — | $0.08 | ||
| Q2 25 | — | $0.06 |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
